The aim of this study is to evaluate the medication knowledge achieved by conventional verbal education and the influence of drug information leaflets in patients with epilepsy. Drug compliance and sources of information of the patients were also examined.
INTRODUCTION
Like other chronic illnesses, antiepileptic drug (AED) therapy in patients with epilepsy is a continuously balancing process between disease control and side effects. Drug-related adverse events are well known to be one of the leading causes of treatment discontinuation by patients themselves. In the treatment of hypertension and depression, medication education has been shown to improve patient compliance with success 1 . Regarding AED therapy, previous studies also show that medication education could significantly reduce drug-related events, including misinterpretation of directions, side effects, and noncompliance 2, 3 . Although the effect of medication education on patient compliance and treatment outcome has been widely recognised, limited data is available at present concerning what patients actually know about their AED treatment regimen 4, 5 .
The conventional medication education in Taiwan is mainly verbal. It emphasises the communication between physician and patient about epilepsy and its treatment. To patients who still have questions about AEDs, clinical pharmacist offers counselling. There are educational pamphlets in the waiting room, but these only cover general health issues. Up to now, there is no published data assessing the medication knowledge and compliance of epilepsy patients in Taiwan.
In this study, we conducted a hospital-based survey in a tertiary care center located in northern Taiwan to assess the AED knowledge and compliance achieved by the conventional verbal education. Furthermore, sources from where patients obtained their AED information and the impact of written AED information were examined. MATERIALS AND METHODS
EMA questionnaire
The questionnaire for epilepsy medication assessment (EMA) was developed and pre-tested on six ambulatory patients at Taipei Veterans General Hospital ( Table 1 ). The EMA consisted of six questions focusing on AED treatment regimen (n = 2), side effects (n = 2), seizure diary (n = 1), and compliance (n = 1). The number of questions that patient gave correct or positive answers was taken as the EMA score. Patients were inquired to specify the sources of their drug information. The survey period ranged from September 1, 2000 to March 31, 2001.
Patient selection
Patients with epilepsy who had taken AEDs for at least 1 year and had the ability to comprehend, read, and write in Chinese were included. These patients were regularly followed in the epilepsy clinic every 4 weeks. Patient consents were obtained before the survey began.
AED information leaflets
AED information leaflets were prepared by clinical pharmacists and revised by neurologists. Each drug had its own leaflet discussing the indication, administration, drug interactions, side effects and therapeutic indicators. The contents of leaflets fulfill the FDA's requirements and can be found on the hospital's website ( http://www.vghtpe.gov.tw/∼pharm /PATIENT SER/ PatientServiceHome.htm) 5 .
Baseline and follow-up assessments
All qualifying patients were asked to fill out the questionnaire at the epilepsy clinic. On completion of the baseline assessment, patients received the AED information leaflets from the clinical pharmacist. A follow-up assessment by filling out the same questionnaire was done on the next 4-week visit.
Serum AED levels
Steady-state drug levels were monitored in the baseline and compared with the patient-reported compliance. Serum carbamazepine, phenytoin, and valproate levels were determined by fluorescence polarization immunoassay (TDxFLx, Abbott Park, IL, USA).
Statistical analysis
Statistical analysis was performed by Pearson chi-square test and linear regression. A P-value of less than 0.05 was considered significant.
RESULTS
Sixty-eight patients met the inclusion criteria. Among them, 51 patients (75.0%) agreed to participate the survey and their demographics are summarised in Results of the baseline and follow-up assessments were listed in Table 3 . In the baseline assessment, 36 patients (70.6%) correctly listed their AEDs and 43 patients (84.3%) knew the dosage. However, 28 patients (54.9%) had no idea about side effects that require immediate medical help, and 20 patients (39.2%) were not knowledgeable about side effects that could happen when first taking AEDs. While 74.5% of patients reported being compliant all the time, 13 patients admitted that, for once or twice per month, they might forget to take the medicine. There were 23 patients (45.1%) who did not regularly keep his/her seizure diary. The averaged EMA score increased from 3.9±1.9 to 5.1 ± 1.7 after the provision of AED leaflets (P < 0.001). In comparison of the baseline, the awareness of side effects was significantly improved (P < 0.05). In this study, 41 patients had their steady-state AED levels monitored. The drug levels were all within the therapeutic range and perfectly matched the self-reported compliance. There were 10 patients who did not have their AED levels checked. Among them, 3 patients were on monotherapy with recently available AED, the rest were on the tapering stage because of satisfied seizure control. Fig. 1 shows the sources of medication information of patients. On average, each patient had 2.8±1.4 different sources of drug information. Physicians were the main providers for verbal education. Pamphlets provided in the waiting room were also considered good references. As illustrated by Fig. 2 , the baseline EMA score positively correlates with the number of information sources (r = 0.62, P < 0.001). There were five patients (9.8%) who would search for medication information from the Internet. All of them were university graduates and their baseline EMA score (4.8 ± 0.7) was apparently higher than the rest of patients (3.8 ± 1.9). Four of these five patients were seizure free in the previous 6 months.
DISCUSSION
Patient education in epilepsy focuses heavily on disease knowledge and self-care, but little on medication education 6, 7 . Goldstein et al. reported that more than one-quarter of epilepsy patients gave incorrect information concerning their AED regimens 8 .
Dawkins et al. also demonstrated that patients had limited knowledge of AED regimens 9 . In this study, the medication knowledge of our patients is similar to Goldstein's finding, but better than Dawkins'. The difference may largely be due to patient sampling. Dawkins' patients were identified from general practices, whereas our study included patients who had received long-term treatment from epilepsy experts. In addition, our study population consisted mostly of patients with good seizure control and who complied optimally with their AED regimens.
This preliminary study found that the EMA score of patients raised 30% by the provision of AED leaflets. Apparently, the written information satisfied the patient's intellectual hunger for medication knowledge. However, we cannot exclude the possibility that patients who agree to participate in a study may be more motivated to know their medication from the start. Besides, since the follow-up assessment used the same questionnaire as the baseline, the results might be confounded by previous experience. The interpretation must be conservative given the realities of this setting.
Patient compliance is a complicated issue in treatment of chronic diseases. Previous studies found that as many as 30-50% of patients do not consistently comply with their AED regimens 10 . Many factors contribute to noncompliance of AED treatment in patients with epilepsy, such as lacking of communication between patient and physician, inadequate medication knowledge, adverse effects, and poor response, etc. To optimize patient adherence, physicians in our epilepsy clinic usually prescribe long-acting preparations and reduce the number of AEDs whenever possible. Therefore, our patients seemed to have similar or even better compliance in comparison with other studies. Most of our patients used pillboxes and the steady-state AED levels were within the therapeutic range. We did not adopt devices such as an electronic medication events monitoring system to determine compliance, so it is uncertain whether the patient took the correct doses at the correct times 11 . After provision of AED leaflets, we found an improvement of AED compliance in the patients, though not statistically significant. In this study, we did not include seizure outcome for analysis because more than half of patients have been seizure free for at least 6 months at enrollment.
More than 60% of patients considered the pamphlets provided in the waiting room very helpful, though too simplified. Owing to the heavy workload in a clinic setting, patients have to wait for a while before they could speak to their physicians. We are now up to place more posters and pamphlets for patients to read while waiting. Our study also revealed that approximately 10% of patients acquired AED knowledge through the Internet; most of them were high education level and had good seizure control. This may predict the general trend in the future. Since most drug-associated problems occur after patients have left the hospital, medication education should be provided not only when the patient is in the hospital, but also at any time when they need it 12 . Because of its accessibility to patients, a medication education website is probably an ideal place for the medical experts to provide appropriate and timely information and for the patients to exchange their drug experiences 13 .
CONCLUSION
A lack of AED knowledge results in decreased patient compliance, which is a serious hindrance to successful treatment and can place the patient at unnecessary risk. The conventional verbal education in Taiwan did not cover the drug-related issues sufficiently. Nonetheless, it achieved patient compliance similar to that of previous studies. Providing patients with written medication information can overcome the shortcomings of verbal education and is an effective intervention strategy to improve medication knowledge and compliance. Owing to the dynamic nature of drug information, we strongly suggest health care professionals to set up medication education websites and provide patients with up-to-date information. Further studies are needed to assess clinical outcomes and investigate the impact of medication education in ambulatory settings.
